Gene · 4437
Papers3,191
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,181 to 1,200 of 3,191
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel Potential Therapeutic Target for E2F1 and Prognostic Factors of E2F1/2/3/5/7/8 in Human Gastric Cancer. | Mol Ther Methods Clin Dev | 2020 | 32953933 | PubTator, text mining | PubMed |
| Analysis of clinicopathological and molecular features of crawling-type gastric adenocarcinoma. | Diagn Pathol | 2020 | 32943104 | PubTator, text mining | PubMed |
| Sequencing for an interdisciplinary molecular tumor board in patients with advanced breast cancer: experiences from a case series. | Oncotarget | 2020 | 32934773 | PubTator, text mining | PubMed |
| Cellular Mechanisms Accounting for the Refractoriness of Colorectal Carcinoma to Pharmacological Treatment. | Cancers (Basel) | 2020 | 32933095 | PubTator, text mining | PubMed |
| Inhibition of DNA Repair in Cancer Therapy: Toward a Multi-Target Approach. | Int J Mol Sci | 2020 | 32932697 | PubTator, text mining | PubMed |
| Whole-Exome Profiling of NSCLC Among African Americans. | J Thorac Oncol | 2020 | 32931935 | PubTator, text mining | PubMed |
| Current understanding of extrachromosomal circular DNA in cancer pathogenesis and therapeutic resistance. | J Hematol Oncol | 2020 | 32928268 | PubTator, text mining | PubMed |
| Immune surveillance activation after neoadjuvant therapy for esophageal adenocarcinoma and complete response. | Oncoimmunology | 2020 | 32923165 | PubTator, text mining | PubMed |
| Hints from a Female Patient with Breast Cancer Who Later Presented with Cowden Syndrome. | J Breast Cancer | 2020 | 32908792 | PubTator, text mining | PubMed |
| Cytogenetically visible inversions are formed by multiple molecular mechanisms. | Hum Mutat | 2020 | 32906200 | PubTator, text mining | PubMed |
| Epigenome-wide association study for transgenerational disease sperm epimutation biomarkers following ancestral exposure to jet fuel hydrocarbons. | Reprod Toxicol | 2020 | 32905848 | PubTator, text mining | PubMed |
| HDAC3 deacetylates the DNA mismatch repair factor MutSβ to stimulate triplet repeat expansions. | Proc Natl Acad Sci U S A | 2020 | 32900932 | PubTator, text mining | PubMed |
| Pre- and Post-Zygotic TP53 De Novo Mutations in SHH-Medulloblastoma. | Cancers (Basel) | 2020 | 32899294 | PubTator, text mining | PubMed |
| Gene expression profiles complement the analysis of genomic modifiers of the clinical onset of Huntington disease. | Hum Mol Genet | 2020 | 32898862 | PubTator, text mining | PubMed |
| Omics Derived Biomarkers and Novel Drug Targets for Improved Intervention in Advanced Prostate Cancer. | Diagnostics (Basel) | 2020 | 32878288 | PubTator, text mining | PubMed |
| Molecular signatures of BRCAness analysis identifies PARP inhibitor Niraparib as a novel targeted therapeutic strategy for soft tissue Sarcomas. | Theranostics | 2020 | 32863940 | PubTator, text mining | PubMed |
| Systems Biology Approaches Reveal Potential Phenotype-Modifier Genes in Neurofibromatosis Type 1. | Cancers (Basel) | 2020 | 32858845 | PubTator, text mining | PubMed |
| The Therapeutic Potential of DNA Damage Repair Pathways and Genomic Stability in Lung Cancer. | Front Oncol | 2020 | 32850380 | PubTator, text mining | PubMed |
| Case report expanding the germline AXIN2- related phenotype to include olfactory neuroblastoma and gastric adenoma. | BMC Med Genet | 2020 | 32807118 | PubTator, text mining | PubMed |
| Molecular correlates of sensitivity to PARP inhibition beyond homologous recombination deficiency in pre-clinical models of colorectal cancer point to wild-type TP53 activity. | EBioMedicine | 2020 | 32799124 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4437/papers?page=60